Pancreatitis Clinical Trials
Here are the 6 most popular medical studies for
Serine Protease Inhibitor
Anti-Inflammatory Therapy for Chronic Pancreatitis
This trial will study whether two anti-inflammatory therapies can reduce damage to transplanted islets and improve long-term outcomes for patients with severe chronic pancreatitis who have had their pancreas removed and their islets transplanted into the liver.
Procedure
Pancreatic Endotherapy for Chronic Pancreatitis
This trial is testing whether treating chronic pancreatitis with just endoscopic ultrasound (EUS) is more effective at reducing pain than adding endoscopic retrograde cholangiopancreatography (ERCP) with pancreatic endotherapy.
Popular filter options for trials
Acute Pancreatitis Clinical Trials
View 19 Acute Pancreatitis medical studies.
Non-Opioid Analgesic
Non-Opioid vs. Opioid Pain Management for Pediatric Pancreatitis
This trial will compare two methods of pain relief for kids with pancreatitis in the emergency room. One group will get the usual care, which often includes opioids, and the other group will get an opioid-sparing method. The trial will help researchers understand how well the new method works and how to design a bigger, better trial.
Anti-inflammatory agent
Auxora for Acute Pancreatitis
This trial will study the effects of Auxora, a new potential treatment for acute pancreatitis, in 216 patients. Patients will be randomly assigned to one of three dose levels of Auxora or one of three placebo volumes. Study drug infusions will occur every 24 hours for three consecutive days for a total of three infusions. Patients will remain hospitalized as per standard of care and once discharged will be asked to complete a daily meal diary and return for a Day 30 safety assessment.
AP Clinical Trials
View 19 AP medical studies.
Non-Opioid Analgesic
Non-Opioid vs. Opioid Pain Management for Pediatric Pancreatitis
This trial will compare two methods of pain relief for kids with pancreatitis in the emergency room. One group will get the usual care, which often includes opioids, and the other group will get an opioid-sparing method. The trial will help researchers understand how well the new method works and how to design a bigger, better trial.
Anti-inflammatory agent
Auxora for Acute Pancreatitis
This trial will study the effects of Auxora, a new potential treatment for acute pancreatitis, in 216 patients. Patients will be randomly assigned to one of three dose levels of Auxora or one of three placebo volumes. Study drug infusions will occur every 24 hours for three consecutive days for a total of three infusions. Patients will remain hospitalized as per standard of care and once discharged will be asked to complete a daily meal diary and return for a Day 30 safety assessment.
Pancreatitis Clinical Trials With No Placebo
View 41 pancreatitis medical studies that do not have a placebo group.
Diagnostic Test
Diagnostic Imaging for Pancreatitis
This trial seeks to understand how MRI can be used to identify pancreatitis & predict long-term complications. It includes tests like endoscopy, blood tests, stool tests & MRI scans. Some participants will receive intravenous secretin.
Non-Opioid Analgesic
Non-Opioid vs. Opioid Pain Management for Pediatric Pancreatitis
This trial will compare two methods of pain relief for kids with pancreatitis in the emergency room. One group will get the usual care, which often includes opioids, and the other group will get an opioid-sparing method. The trial will help researchers understand how well the new method works and how to design a bigger, better trial.
View More Trials
See another 24 medical studies focused on .
Frequently Asked Questions
Introduction to
What are the top hospitals conducting undefined research?
When it comes to cutting-edge clinical trials in an unspecified medical condition, several top hospitals are leading the way. In Pittsburgh, the University of Pittsburgh Medical Center is making significant strides with four active trials and a total of eight completed studies dedicated to this mysterious condition. Since their first recorded trial in 2010, they have been at the forefront of uncovering breakthroughs in diagnosis and treatment.
Meanwhile, the University of Minnesota in Minneapolis has also demonstrated its commitment to advancing knowledge about this enigmatic ailment. With three ongoing undefined trials and a history of eight previous investigations since initiating their first trial in 2010, they are actively contributing to our understanding of this condition.
Taking part in this important research is the Medical University of South carolina located in Charleston. They currently have three active undefined trials underway and have already conducted twelve such studies since recording their initial trial back in 2011. Their dedication speaks volumes about their determination to unravel the mysteries behind this complex illness.
In Cincinnati, researchers at The Cincinnati Children's Hospital Medical Center are tirelessly working towards finding answers as well. While having two ongoing undefined clinical trials, they have previously conducted six exploratory investigations since embarking on their pioneering journey just seven years ago during 2014.
Lastly joining these prestigious institutions' efforts is Beth Israel Deaconess Medical Center situated within Boston's medical hub. With two current undefined clinical trials underway and seven previous studies under their belt since recording their debut experiment back during 2004; theirs' too signifies an unwavering commitment toward tackling unknown aspects related to aforementioned health concern.
These notable hospitals epitomize how collaboration between esteemed institutions across different locations can bring us closer to solving medical mysteries that impact countless lives worldwide
Which are the best cities for undefined clinical trials?
When it comes to undefined clinical trials, several cities show promise in ongoing research and development. Los Angeles, California leads the way with 8 active trials exploring treatments like 0.5 mg/kg (0.3125 mL/kg), ERCP with miES, and Regular Diet interventions. Indianapolis, Indiana follows closely behind with 5 ongoing studies focused on advancements such as ERCP with miES and Dose Escalation Level assessments. Additionally, Pittsburgh, Pennsylvania and Charleston, South carolina both have 4 active trials investigating various approaches including ERCP with miES and Quantitative Sensory Test 1 evaluations. Baltimore, Maryland also joins these cities in offering potential breakthroughs through its own set of 4 active trials examining treatments like Rectal Indomethacin. These cities provide individuals participating in undefined clinical trials access to cutting-edge research that may contribute to improved patient outcomes in the future.
Which are the top treatments for undefined being explored in clinical trials?
Clinical trials are paving the way for innovative treatments in undefined conditions. Among the top contenders, ketorolac and rectal indomethacin are currently being explored in two active trials each, with five and three all-time undefined trials respectively. These treatments have been making strides since their introduction in 2016 and 2014 respectively. Additionally, proton pump inhibitors and hydrocortisone show promise with one active trial each, marking a new era of potential therapies that could offer hope to patients facing these undefined conditions as early as 2023 and 2022 respectively. The relentless pursuit of scientific discovery continues to push boundaries and bring us closer to effective treatment options.
What are the most recent clinical trials for undefined?
The field of clinical trials is continuously advancing, with recent studies exploring new avenues for undefined conditions. One noteworthy trial involves the use of pirfenidone as a potential treatment option. With both Phase 1 and Phase 2 trials currently underway since August 2023, researchers are eager to evaluate its efficacy in addressing this condition. Additionally, another trial focuses on dose escalation levels specifically tailored for patients with undefined concerns, aiming to determine the optimal dosage for effective treatment. Lastly, imaging stratification of stages of pancreatitis has emerged as an area of interest within the medical community through a Phase 4 study that commenced in January 2023. These ongoing investigations hold promise in expanding our understanding and improving outcomes for individuals facing undefined conditions.
What undefined clinical trials were recently completed?
Recently, two clinical trials addressing undefined medical conditions have reached completion, representing significant progress in understanding and treating these ailments. In October 2021, AbbVie concluded a trial investigating the potential of CREON. Similarly, Mayo Clinic wrapped up a study testing Indomethacin in July 2020. These achievements highlight the ongoing efforts of researchers towards uncovering effective treatment options for complex medical conditions that are not explicitly specified here.